Women's sexual behavior. Population-based study among 65 000 women from four Nordic countries before introduction of human papillomavirus vaccination
- 5 February 2011
- journal article
- Published by Wiley in Acta Obstetricia et Gynecologica Scandinavica
- Vol. 90 (5), 459-467
- https://doi.org/10.1111/j.1600-0412.2010.01066.x
Abstract
Sexual behavior is of public health interest because of the association with reproductive health and sexually transmitted infections such as human papillomavirus, which is the causal factor of cervical cancer. The aim of the study was to describe patterns in women's sexual behavior in four Nordic countries. Population-based cross-sectional study. Denmark, Iceland, Norway, and Sweden (November 2004-June 2005). A random sample of 18-45-year-old women from the female population in the four participating Nordic countries. The participation rate ranged from 81.3% in Denmark to 54.5% in Iceland. In total, 65 623 women were included. Each participant completed a structured questionnaire containing questions about sociodemographic factors, lifestyle factors and sexual behavior. Age-specific and country-specific descriptive measures of sexual behavior, notably age at first intercourse and lifetime number of partners. In addition, risk factors for having had multiple (>10) sexual partners were examined. Overall, median age at first intercourse was 16, and 30.2% (95% CI: 29.9-30.6) of the participating women reported having had ≥10 partners. There was great variation with birth cohort but limited variation between countries. The main correlates of multiple sexual partners were increasing age at enrollment, a higher alcohol intake and young age at first intercourse. These measurements of sexual behavior before the introduction of national human papillomavirus vaccination programs will form the basis for a comparison with a similar survey performed after vaccination has been introduced.Keywords
This publication has 27 references indexed in Scilit:
- Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24–45 years: a randomised, double-blind trialThe Lancet, 2009
- Type-Specific HPV Infection and Multiple HPV Types: Prevalence and Risk Factor Profile in Nearly 12,000 Younger and Older Danish WomenSexually Transmitted Diseases, 2008
- The Burden of Genital Warts: A Study of Nearly 70,000 Women from the General Female Population in the 4 Nordic CountriesThe Journal of Infectious Diseases, 2007
- Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trialThe Lancet, 2007
- The Epidemiology of Human Papillomavirus Infection and Cervical CancerDisease Markers, 2007
- Sexual behaviour in context: a global perspectiveThe Lancet, 2006
- Pelvic inflammatory disease in adolescentsCurrent Opinion in Obstetrics and Gynecology, 2006
- Chapter 4: Burden and management of non-cancerous HPV-related conditions: HPV-6/11 diseaseVaccine, 2006
- A Longitudinal Study of Genital Human Papillomavirus Infection in a Cohort of Closely Followed Adolescent WomenThe Journal of Infectious Diseases, 2005
- Sexual Behavior and Selected Health Measures: Men and Women 15-44 Years of Age, United States, 2002Published by American Psychological Association (APA) ,2005